AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimrator-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Bkyula Biotech

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimrator-M2 Tablet SR

DiaBeta-Duo SR tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. DiaBeta-Duo SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar; discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women should consult their physician. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Primary Ingredients of Glimrator-M2 Tablet SR

No text provided to rephrase.

Uses of Glimrator-M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimrator-M2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimrator-M2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimrator-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimrator-M2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimrator-M2 Tablet SR whole; do not crush, chew, or break it. Administer this medication with food.

How Glimrator-M2 Tablet SR works:

Glimepiride and Metformin, combined as Glimrator-M2 SR tablets, offer a dual approach to diabetes management. Glimepiride, a sulfonylurea agent, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimrator-M2 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimrator-M2 tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimrator-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimrator-M2 Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Physician consultation is recommended. Glimrator-M2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimrator-M2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically advised for those with mild to moderate liver disease; its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimrator-M2 Tablet SR :

Should you forget a Glimrator-M2 Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimrator-M2 Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Glimrator-M2 Tablet SR

Retain this medication within its original, sealed container. Follow the storage directions provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Indeed, Glimrator-M2 Tablet SR use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare but potentially dangerous adverse reaction is linked to metformin use and particularly warrants caution in patients with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should any of these symptoms appear, discontinue Glimrator-M2 Tablet SR and seek immediate medical attention.
Glimepiride and Metformin, combined as Glimrator-M2 Tablet SR, manage type 2 diabetes mellitus (DM) in adults. This dual-action medication enhances blood sugar control when coupled with a balanced diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing cellular insulin responsiveness. This formulation is unsuitable for type 1 DM.
Glimrator-M2 Tablet SR may cause common adverse reactions including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Glimrator-M2 Tablet SR administration can indeed lead to Vitamin B12 deficiency. This medication impairs the body's absorption of Vitamin B12 within the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia, neurological complications including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait disturbances. Preventive measures, proposed by some studies, involve supplemental Vitamin B12 intake at least annually.
Indeed, Glimrator-M2 Tablet SR can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimrator-M2 Tablet SR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Glimrator-M2 Tablet SR
53
MRP 65
18% off